News
LAB+ Startups Join Global Biotech Leaders at BIO International Convention
Nicolás Tambucho, CEO of Guska; Carlos Palma, CEO of B4-RNA; Dayana Benchoam, COO of Locbio; and Juan Gandioli, biotechnology engineer at Guska, participated in the BIO International Convention, a flagship global event in the biotechnology industry held in Boston. “In Uruguay, we are experiencing an unprecedented moment in the development of life...
Antonio Bordería Joins Guska as Senior Business Advisor
Guska, one of the startups in the LAB+ portfolio, has announced the addition of Antonio Bordería as Senior Business Advisor. Bordería is a former researcher at the Institut Pasteur in Paris, holds a PhD in molecular biology, and currently serves as Vice President at a tech company focused on artificial intelligence and data. “I'm excited to be...
Locbio took part in SynBioBeta, in Silicon Valley
Felipe Trajtenberg and Dayana Benchoam, from the startup Locbio, attended SynBioBeta (The Global Synthetic Biology Conference), which was held in Silicon Valley. In addition, Trajtenberg was a panelist on “How Latin America Is Building Biotech Power‑Hubs,” alongside representatives from The Ganesah Lab, GRIDX, Allbiotech, and SynBioBR.The...
Read the first edition of our newsletter here.
(It’s in Spanish, but there’s a translation option at the top right of the menu)
LAB+ in the Media:
Local
Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo
Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse
En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’
Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio
En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer
La Diaria – What do the first four start-ups of the LAB+ seek to develop?
Telemundo (Channel 12) – Scaffold Biotech: more efficient vaccines for animals
En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska
Subrayado (Channel 10) – LAB+ closed its first financing cycle
Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+
La Diaria – Conversations with the first four biotech start-ups funded by LAB+
El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups
Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups
Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA
Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups
El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?
Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative
Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies
International
Yale Podcasts – Interview with Gonzalo Moratorio, Guska’s founder
Tekios – LAB+ international call for scientific projects and start-ups
SwissInfo – LAB+ international call for scientific projects and start-ups
Latin American Post – LAB+ pioneers a new era of scientific start-ups in Uruguay and beyond.
Infobae – Closing of first round of financing for LAB+.
EFE – The Institut Pasteur de Montevideo presents LAB+, with four start-ups.
Investing – The Institut Pasteur de Montevideo launches the LAB+ iniciative.
ABC (Paraguay) – With four start-ups, the Institut Pasteur de Montevideo launches the LAB+.
Bloomberg – New Venture Capital Fund Eyes Latin American Science Start-ups.
Bloomberg online – New venture capital fund sets its sights on Latin American scientific start-ups.
Perfil – A new venture capital fund targets Latin American science.
iProUP – Support for startups: Ficus Capital, biotech fund, looks for unicorns in Latin America.
Yahoo Finances – Biotech fund seeks unicorns in LatAm.